| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
| | IP | CI | | Vitamin A Blache | 5 g | 3.85 | 13.40 | 10 % | | Ophtalmic ointment: Retinoli Palmitas 15000 UI | Bausch & Lomb Swiss AG | B / SL | FB | | G |  |
| | IP | CI | | Vitamin A 10'000 E/g Dispersa | 4 g | PR | 9.30 | k.A. | | Ophtalmic ointment: Retinoli Acetas 10000 UI | Novartis Ophthalmics AG | B | FB | | G |  |
|
| | IP | CI | | NaCl 5 % Dispersa | 10 ml | PR | PR | k.A. | | Eye drops: Natrii Chloridum 50 mg/ml | OmniVision AG | B | FB | | G |  |
|
| | IP | CI | PP | Ikervis, 1 mg/ml collyre en émulsion (unidoses) | 30 x 0.3 ml | PR | PR | k.A. | | | Santen SA | B | FB | | G |  |
| | IP | CI | PP | Ikervis, 1 mg/ml collyre en émulsion (unidoses) | 90 x 0.3 ml | PR | PR | k.A. | | | Santen SA | B | FB | | G |  |
| | IP | CI | | Verkazia | 120 x 0.3 ml | PR | PR | k.A. | | Augentropfen Emulsion: Ciclosporinum 1 mg/ml | Santen SA | B | FB | | G |  |
|
| | IP | CI | | Lacrycon | 4 x 5 unidose(s) | 8.73 | 18.55 | 10 % | | Ophtalmic gel: Acidum Hyaluronicum | THEA Pharma S.A. | B / SL / SO | FB | | G |  |
| | IP | CI | | Lacri-Vision | 20 x 0.65 ml | 5.50 | 15.20 | 10 % | | Ophtalmic gel: Natrii Hyaluronas | OmniVision AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Lacri-Vision | 60 x 0.65 ml | 15.68 | 33.45 | 10 % | | Ophtalmic gel: Natrii Hyaluronas | OmniVision AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Lacri-Vision | 90 x 0.65 ml | 23.51 | 42.00 | 10 % | | Ophtalmic gel: Natrii Hyaluronas | OmniVision AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Lacrinorm | 10 g | 3.21 | 5.95 | 10 % | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Liposic | 10 g | 2.86 | 5.30 | 10 % | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Liposic Fluid UD | 30 x 0.6 g | 6.66 | 12.30 | 10 % | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Siccafluid | Flasche(n) à 10 g | 4.14 | 7.65 | 10 % | | Ophtalmic gel: Carbomerum 974P 2.5 mg | THEA Pharma S.A. | D / SL | FB | | G |  |
| | IP | CI | | Siccafluid UD 0.25 % | 30 x 0.5 g | 6.58 | 12.15 | 10 % | | Ophtalmic gel: Carbomerum 974P 2.5 mg | THEA Pharma S.A. | D / SL | FB | | G |  |
| | IP | CI | | Viscotears | 10 g | 3.43 | 6.35 | 10 % | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Viscotears | 3 x 10 g | 9.76 | 18.00 | 10 % | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Viscotears SDU | 30 x 0.6 g | 7.03 | 13.00 | 10 % | | Ophtalmic gel (monodoses): Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | ● D / SL | FB | | G |  |
| | IP | CI | | Cellufluid | 10 ml | 3.32 | 6.15 | 10 % | | Eye drops: Carmellosum Natricum 5 mg/ml | AbbVie AG | D / SL | FB | | G |  |
| | IP | CI | | Celluvisc | 30 1 unidose(s) à 0.4 ml | 4.96 | 9.15 | 10 % | | Eye drops: Carmellosum Natricum 10 mg/ml | AbbVie AG | D / SL | FB | | G |  |
| | IP | CI | | Celluvisc | 90 1 unidose(s) à 0.4 ml | 12.54 | 23.15 | 10 % | | Eye drops: Carmellosum Natricum 10 mg/ml | AbbVie AG | D / SL | FB | | G |  |
| | IP | CI | | Fluidose | 30 1 unidose(s) à 0.4 ml | 8.35 | 15.40 | 10 % | | Eye drops: Carbomerum 980 1.3 mg/g | Cheplapharm Schweiz GmbH | D / SL | FB | | G |  |
| | IP | CI | | Lacrifluid | 10 ml | 2.73 | 5.05 | 10 % | | Eye drops: Carbomerum 980 1.3 mg/g | Cheplapharm Schweiz GmbH | D / SL | FB | | G |  |
| | IP | CI | | Lacrinorm F UD | 30 1 unidose(s) à 0.6 ml | 6.85 | 12.65 | 10 % | | Eye drops: Carbomerum 980 2 mg/ml | Bausch & Lomb Swiss AG | ● D / SL | FB | | G |  |
| | IP | CI | | Lacrinorm F UD | 60 1 unidose(s) à 0.6 ml | 11.66 | 21.55 | 10 % | | Eye drops: Carbomerum 980 2 mg/ml | Bausch & Lomb Swiss AG | D / SL | FB | | G |  |
| | IP | CI | | Oculac | 10 ml | 2.32 | 4.30 | 10 % | | Eye drops: Povidonum k 25 50 mg/ml | Alcon Switzerland SA | D / SL | FB | | G |  |
| | IP | CI | | Oculac | 3 x 10 ml | 5.93 | 10.95 | 10 % | | Eye drops: Povidonum k 25 50 mg/ml | Alcon Switzerland SA | ● D / SL | FB | | G |  |
| | IP | CI | | Oculac SDU | 20 1 unidose(s) à 0.4 ml | 4.15 | 7.65 | 10 % | | Eye drops: Povidonum k 25 50 mg | Alcon Switzerland SA | ● D / SL | FB | | G |  |
| | IP | CI | | Oculac SDU | 60 1 unidose(s) à 0.4 ml | 10.48 | 19.35 | 10 % | | Eye drops: Povidonum k 25 50 mg | Alcon Switzerland SA | ● D / SL | FB | | G |  |
| | IP | CI | PP | Optava Unit Dose | 30 1 unidose(s) à 0.4 ml | 9.19 | 16.95 | 10 % | | Eye drops: Carmellosum Natricum 5 mg/ml | AbbVie AG | D / SL | FB | | G |  |
| | IP | CI | | Protagent | 10 ml | 3.14 | 5.80 | 10 % | | Eye drops: Povidonum k 25 20 mg/ml | Alcon Switzerland SA | D / SL | FB | | G |  |
| | IP | CI | | Protagent SE | 20 x 0.4 ml | 5.72 | 10.55 | 10 % | | Eye drops: Povidonum k 25 20 mg/ml | Alcon Switzerland SA | D / SL | FB | | G |  |
| | IP | CI | | Protagent SE | 80 x 0.4 ml | 19.23 | 35.50 | 10 % | | Eye drops: Povidonum k 25 20 mg/ml | Alcon Switzerland SA | D / SL | FB | | G |  |
| | IP | CI | | Siccaprotect | 10 ml | 2.04 | 3.75 | 10 % | | Eye drops: 2 Active Agents | URSAPHARM Schweiz GmbH | D / SL | FB | | G |  |
| | IP | CI | | Lacrycon | 12 x 5 | PR | PR | k.A. | | Ophtalmic gel: Acidum Hyaluronicum | THEA Pharma S.A. | B | FB | | G |  |
| | IP | CI | | Lacrycon | 18 x 5 | PR | PR | k.A. | | Ophtalmic gel: Acidum Hyaluronicum | THEA Pharma S.A. | B | FB | | G |  |
| | IP | CI | | Lacryvisc | 10 g | 3.26 | 6.00 | k.A. | | Ophtalmic gel: Carbomerum 974P 3 mg | Alcon Switzerland SA | D | FB | | G |  |
| | IP | CI | | Lacryvisc SE | 20 1 unidose(s) à 0.5 g | 5.44 | 10.05 | k.A. | | Ophtalmic gel: Carbomerum 974P 3 mg | Alcon Switzerland SA | D | FB | | G |  |
| | IP | CI | | Lacryvisc SE | 50 1 unidose(s) à 0.5 g | 12.15 | 22.40 | k.A. | | Ophtalmic gel: Carbomerum 974P 3 mg | Alcon Switzerland SA | D | FB | | G |  |
| | IP | CI | | Liposic | 3 x 10 g | 9.77 | 18.05 | k.A. | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D | FB | | G |  |
| | IP | CI | | Liposic Fluid UD | 10 x 0.6 g | PR | PR | k.A. | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D | FB | | G |  |
| | IP | CI | | Liposic Fluid UD | 60 x 0.6 g | 14.49 | 26.70 | k.A. | | Ophtalmic gel: Carbomerum 980 2 mg | Bausch & Lomb Swiss AG | D | FB | | G |  |
| | IP | CI | | Fluidose | 10 1 unidose(s) à 0.4 ml | PR | PR | k.A. | | Eye drops: Carbomerum 980 1.3 mg/g | Cheplapharm Schweiz GmbH | D | FB | | G |  |
| | IP | CI | | Tears Naturale | 10 ml | PR | 9.50 | k.A. | | Eye drops: 2 Active Agents | Alcon Switzerland SA | D / LPPV | FB | | G |  |
|
| | IP | CI | | Cystadrops 3.8 mg/ml | 5 ml | PR | PR | k.A. | | Eye drops: Mercaptaminum 3.8 mg/ml | Recordati AG | B | FB | | G |  |
|
| | IP | CI | | Oxervate | 7 | PR | PR | k.A. | | Eye drops: Cenegerminum | Dompé International SA | B | FB | | G |  |
|
| | IP | CI | | Xiidra | 60 x 0.2 ml | PR | PR | k.A. | | Eye drops: Lifitegrastum 50 mg/ml | Bausch & Lomb Swiss AG | B | FB | | G |  |
|
L | | IP | CI | | Luxturna 5 x 10e12 | | 319054.57 | 327657.80 | 10 % | | Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung: Voretigenum Neparvovecum 5 | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
|
| | | CI | A | Visiodoron Euphrasia comp. | 5 g | PR | PR | k.A. | | | Weleda AG | D | FB | | G |  |
| | | | A | Wala Euphrasia Einzeldosis-Augentropfen | 15 1 unidose(s) à 0.5 ml | PR | PR | k.A. | | Eye drops: 2 Active Agents | WALA Schweiz AG | D | FB | | G |  |
| | | CI | A | Visiodoron Euphrasia Monodosen | 20 x 0.4 ml | PR | PR | k.A. | | Eye drops (monodoses): Euphrasia Officinalis D3 397.34mg / 0.4ml | Weleda AG | D | FB | | G |  |
| | | CI | A | Visiodoron Euphrasia | 10 ml | PR | PR | k.A. | | anthroposophisches Arzneimittel: Euphrasia Officinalis D3 985.9 mg/g | Weleda AG | D | FB | | G |  |
|
| | | CI | H | Mucokehl D5 | 5 ml | PR | PR | k.A. | | Eye drops: Mucor Racemosus e Volumine Cellulae (Lyophil., Steril.) D5 Aquos (Hab 5B) | ebi-pharm ag | D | FB | | G |  |
| | | CI | H | Similasan Allergisch reagierende Augen | 10 ml | PR | PR | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | H | Similasan Trockene Augen | 10 ml | PR | PR | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | | Similasan überanstrengte Augen N | 20 | PR | PR | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | H | Oculoheel | 20 x 0.45 ml | PR | PR | k.A. | | Augentropfen Monodosen: 4 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | | Similasan Allergisch reagierende Augen N | 20 x 0.4 ml | PR | PR | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | | Similasan Entzündete Augen N | 20 x 0.4 ml | PR | PR | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | | Similasan Trockene Augen N | 20 x 0.4 ml | PR | PR | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | H | Similasan Entzündete Augen, Augentropfen 10 ml | 10 ml | PR | PR | k.A. | | Solution: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |
| | | CI | H | Similasan Überanstrengte Augen, Augentropfen 10 ml | 10 ml | PR | PR | k.A. | | Solution: 3 Active Agents | T&S Eye Care Management AG | D | FB | | G |  |